Your browser doesn't support javascript.
loading
MiR-326: Promising Biomarker for Cancer.
Pan, Yao-Jie; Wan, Jian; Wang, Chun-Bin.
Afiliação
  • Pan YJ; Department of Oncology, The Affiliated Yancheng Hospital of Medicine School of Southeast University, The Third People's Hospital of Yancheng, Yancheng 224001, People's Republic of China.
  • Wan J; Department of General Surgery, Center for Difficult and Complicated Abdominal Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200092, People's Republic of China.
  • Wang CB; Department of Oncology, The Affiliated Yancheng Hospital of Medicine School of Southeast University, The Third People's Hospital of Yancheng, Yancheng 224001, People's Republic of China.
Cancer Manag Res ; 11: 10411-10418, 2019.
Article em En | MEDLINE | ID: mdl-31849530
ABSTRACT
MicroRNAs (miRNAs) are small non-coding and highly conserved RNAs that act in biological processes including cell proliferation, invasion, apoptosis, metabolism, signal transduction, and tumorigenesis. The previously identified miRNA-326 (miR-326) has been reported to participate in cellular apoptosis, tumor growth, cell invasion, embryonic development, immunomodulation, chemotherapy resistance, and oncogenesis. This review presents a detailed overview of what is known about the effects of miR-326 on cell invasion, metastasis, drug resistance, proliferation, apoptosis, and its involvement in signaling pathways.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article